- Report
- April 2024
- 380 Pages
Global
From €5269EUR$5,450USD£4,528GBP
- Report
- April 2024
- 196 Pages
Global
From €5269EUR$5,450USD£4,528GBP
- Report
- February 2024
- 120 Pages
Global
From €4592EUR$4,750USD£3,947GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1933EUR$2,000USD£1,662GBP
- Clinical Trials
- April 2024
- 180 Pages
Global
From €2900EUR$3,000USD£2,493GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1208EUR$1,250USD£1,039GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1208EUR$1,250USD£1,039GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1450EUR$1,500USD£1,246GBP
- Report
- August 2023
- 133 Pages
Global
From €7250EUR$7,500USD£6,232GBP
- Report
- July 2023
- 129 Pages
Global
From €7250EUR$7,500USD£6,232GBP
- Drug Pipelines
- July 2023
- 30 Pages
Global
From €2658EUR$2,750USD£2,285GBP
- Report
- October 2023
- 182 Pages
Global
From €4737EUR$4,900USD£4,071GBP
- Report
- October 2023
- 189 Pages
Global
From €4737EUR$4,900USD£4,071GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1208EUR$1,250USD£1,039GBP
- Report
- January 2024
- 200 Pages
Global
From €4012EUR$4,150USD£3,448GBP
- Report
- January 2024
- 200 Pages
Global
From €4012EUR$4,150USD£3,448GBP
- Report
- November 2023
- 161 Pages
Global
From €2417EUR$2,500USD£2,077GBP
- Report
- December 2023
- 117 Pages
Global
From €10629EUR$10,995USD£9,136GBP
- Report
- July 2020
- 280 Pages
Global
From €4736EUR$4,899USD£4,071GBP
- Report
- April 2019
- 208 Pages
Global
From €2899EUR$2,999USD£2,492GBP
The Antidepressant market is a subset of the Mental Disorders Drugs market, which includes medications used to treat mental health conditions such as depression, anxiety, bipolar disorder, and schizophrenia. Antidepressants are the most commonly prescribed medications for treating depression, and are typically divided into two categories: selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). These medications work by increasing the levels of serotonin and norepinephrine in the brain, which can help to improve mood and reduce symptoms of depression.
Some of the major companies in the Antidepressant market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. These companies produce a variety of antidepressants, including SSRIs and SNRIs, as well as other medications used to treat mental health conditions. Show Less Read more